The highest-paid pharma and biotech CEOs of 2024news2025-07-08T14:00:05+00:00July 8th, 2025|Endpoints News|
Novartis maps launch of malaria drug for newborns after Swiss approvalnews2025-07-08T05:15:03+00:00July 8th, 2025|Endpoints News|
Doctors sue RFK Jr., HHS over changes to Covid-19 vaccine schedulenews2025-07-07T19:34:38+00:00July 7th, 2025|Endpoints News|
Trump’s tax cut law expands orphan drug exclusions, could upend 340B programnews2025-07-07T19:14:19+00:00July 7th, 2025|Endpoints News|
The fight over state PBM laws will continue after Supreme Court denial news2025-07-07T18:26:38+00:00July 7th, 2025|Endpoints News|
KalVista CEO talks FDA drug approval, review delaynews2025-07-07T18:05:10+00:00July 7th, 2025|Endpoints News|
FDA approves KalVista’s HAE drug after review delaynews2025-07-07T10:40:37+00:00July 7th, 2025|Endpoints News|
Judge rules against Trump administration’s removal of HHS web contentnews2025-07-03T16:31:09+00:00July 3rd, 2025|Endpoints News|
Novartis’ Cosentyx fails Phase 3 study for autoimmune diseasenews2025-07-03T15:07:04+00:00July 3rd, 2025|Endpoints News|
The Trump administration is promoting wearable health devices — with or without evidencenews2025-07-03T13:30:44+00:00July 3rd, 2025|Endpoints News|
